Carta Healthcare Secures $25 Million in Series B Funding with Additional Investments from Memorial Hermann Health System and UnityPoint Health

Matt Hollingsworth, co-founder and CEO of Carta Healthcare.

Top health systems invest in innovative technology company to simplify data abstraction and deliver data insights to drive quality improvement

Carta Healthcare, a company whose mission is to improve patient care by harnessing the value of clinical data, finalized the closing of its $25 million series B financing, thanks to additional investments from leading health systems Memorial Hermann Health System and UnityPoint Health.

These additional investments follow the initial $20 million series B financing announced in November 2022, which included investors such as Paramark Ventures, Frist Cressey Ventures, American College of Cardiology, Asset Management Ventures, CU Healthcare Innovation Fund, Mass General Brigham, Maverick Ventures Investment Fund, and Storm Ventures.

“I am thrilled to have such visionary and forward-thinking investors who share our passion for accelerating the development of healthcare technologies,” said Matt Hollingsworth, co-founder and CEO of Carta Healthcare. “This funding will allow us to scale operations and product development making more products accessible to more health systems.”

Carta Healthcare is a leading provider of collection, analysis, and insights into clinical data. Backed by state-of-the-art technology and a team of experienced clinicians, the company delivers the highest quality registry data abstraction, reporting, and analytics to leading healthcare systems nationwide. By transforming the abstraction process and implementing powerful analytic capabilities, Carta Healthcare informs data-driven decisions that can improve patient outcomes, drive data processing cost savings, and enable healthcare professionals to spend more time on patient care rather than data entry.

“Memorial Hermann invests in solutions that align with our vision to create healthier communities,” said Feby Abraham, executive vice president and chief strategy officer for Memorial Hermann. “Carta’s platform gives providers and researchers access to timely, actionable analytics and insights that can lead to meaningful quality improvements and enhanced research capabilities.”

“There has never been a time in healthcare when it has been more important for us to embrace automation,” said Matt Warrens, managing director of UnityPoint Ventures. “Automation in healthcare isn’t about closing the gap between need and lack of clinicians, it’s about equipping our clinicians with tools they need to be able to continue to provide high quality care more efficiently.”